- « Previous
- 1
- 2
- 3
- 4
World Tuberculosis Day: Treating the untreatable
March 24, 2019With 84,000 cases of drug-resistant tuberculosis, India has the highest burden of DR-TB in the world. In Mumbai, MSF has been providing not just medical treatment but holistic care to people living with DR-TB. Watch this video to find out...
Read moreTuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
February 14, 2019Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline. Nandita...
Read moreTuberculosis: TB activists challenge Johnson & Johnson patent application on bedaquiline in India
February 8, 2019Mumbai/Cape Town - Doctors Without Borders/Médecins Sans Frontières (MSF) is supporting a patent challenge filed in India this week by two tuberculosis survivors, to prevent pharmaceutical corporation Johnson & Johnson (J&J) from extending its monopoly on the tuberculosis drug bedaquiline....
Read moreRenewed hope- Stories of four patients fighting drug-resistant-TB in Mumbai
March 24, 2018Name : Designation : Interviews conducted & written by DVL Padma Priya for MSF For World TB Day 2018, we celebrate the courage and endurance of four MSF patients who are currently undergoing treatment for drug-resistant TB (DR-TB). Pooja,...
Read moreMSF: India’s decision to give Pfizer unmerited patent on lifesaving pneumonia vaccine limits access for children globally
November 20, 2017At High Court of Delhi hearing tomorrow, Doctors Without Borders/Médecins Sans Frontières (MSF) will urge India to remain the “pharmacy of the developing world” and rethink decision that solidifies Pfizer monopoly on critical pneumonia vaccine New York/ New Delhi, November 20, 2017 —...
Read moreIndia skips 6 Of 16 key WHO recommendations on TB
August 12, 2017India does not implement six out of the 16 key World Health Organisation (WHO)- recommended tuberculosis (TB) control policies in diagnosis, patient care and treatment, a new global report has found. Four other policies that are a part of the national policy...
Read moreMumbai: A new life with new tuberculosis drugs
December 1, 2016Increasingly drug-resistant strains of tuberculosis (TB) are on the rise in India, particularly in hotspots such as Mumbai. Two new TB drugs, bedaquiline and delaminid, show promising results and offer renewed hope to patients whose TB strains are resistant to...
Read moreIndia: Renewed hope with new drugs
October 28, 2016Two new drugs, bedaquiline and delamanid, are proving to be the very last lifeline for tuberculosis (TB) patients with the most extreme forms of drug resistance. While a few patients benefit from these new drugs in India, many die before being able...
Read more